• 中文
  • 登录
  • 联系我们
×
目录产品 » SARS-CoV-2 Nucleocapsid S-RBD Fusion protein

SARS-CoV-2 Nucleocapsid S-RBD Fusion protein

*This product is under development*
Synonyms SARS-CoV-2 NP S-RBD fusion
Description SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells.
Species SARS-CoV-2
Source E.coli
Tag His tag
Biological Activity SARS-CoV-2 Nucleocapsid S-RBD Fusion protein can bind with Human ACE2 in functional ELISA assay.

Molecular Weight Predicted molecular weight: 74 KD
Purity > 80% as analyzed by SDS-PAGE
Formulation Liquid
Component PBS, pH 7.4,10% Glycerol
Storage The product can be stored at -20°C or below. Avoid repeated freezing and thawing cycles. The shelf life of the product is unspecified.
Note For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.

  • SARS-CoV-2 Nucleocapsid S-RBD Fusion Protein
  • SARS-CoV-2 Nucleocapsid S-RBD Fusion Protein

    SARS-CoV-2 Nucleocapsid S-RBD Fusion protein can bind with Human ACE2 in functional ELISA assay.




请点击此处查找更多相关文献







更多产品文件类型 >>